Zhibao Technology Inc. Class A Ordinary Shares
NASDAQ:ZBAOInsurance - Brokers
-$0.47 today
- Market cap
- $78.40M
- Beta
- 1.55
- P/E (TTM)
- -7.8
- EPS (TTM)
- -$2.03
Volume 0.37M
Average 25.27M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Zhibao Technology Inc. Class A Ordinary Shares
NASDAQ:ZBAO
Intrinsic Alpha fair value
Locked
Current Price
$2.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A0 analysts |
| Revenue | N/A | N/A | +36.8% | +46.9% (2yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Recent growth has been strongest in Revenue at +36.8% over three years. Forward estimates point to Revenue at +46.9% (2yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Akso Health Group NASDAQ:AHG | $1.17B | $1.37 | Not rated | -3.1 | -11.20% |
Churchill Capital Corp IX Ordinary Shares NASDAQ:CCIX | $398.89M | $10.88 | Not rated | 42.4 | +2.35% |
Greenidge Generation Holdings Inc. NASDAQ:GREE | $51.50M | $2.84 | Not rated | 6.9 | +121.87% |
Kentucky First Federal Bancorp NASDAQ:KFFB | $46.42M | $5.74 | Overvalued | 26.9 | +26.33% |
Continue the stock analysis
Jump to another research area for this company.